Shyh-Yau Wang
Overview
Explore the profile of Shyh-Yau Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tai Y, Leung J, Wang S, Leung H, Chan A
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39409083
The routine use of granulocyte colony-stimulating factor (GCSF) is not recommended for the prevention or treatment of chemotherapy-induced neutropenia or febrile neutropenia because risks associated with certain types of cancers,...
2.
Leung H, Wang S, Lin C, Chan A
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272840
This study aims to examine whether radiation therapy doses are related to incidences of carotid artery stenosis and brain necrosis in a large-scale real-world database. We identified a cohort of...
3.
Leung J, Leung H, Wang S, Yip Fion H, Chan A
Medicine (Baltimore)
. 2024 May;
103(21):e38183.
PMID: 38788019
Background: We aimed to compare 7 newer immunotherapies and targeted therapies for platinum-resistant relapsed ovarian cancer. Methods: We conducted a comprehensive search of PubMed, EMBASE, and Cochrane Library electronic databases...
4.
Leung J, Wang S, Leung H, Chan A
Front Oncol
. 2024 Mar;
14:1344798.
PMID: 38434681
Background: Portal vein tumor thrombus (PVTT) is a common complication and an obstacle to treatment, with a high recurrence rate and poor prognosis. There is still no global consensus or...
5.
Lai S, Wang S, Chan A, Leung J, Yip H
Expert Rev Pharmacoecon Outcomes Res
. 2024 Feb;
24(4):541-549.
PMID: 38372034
Introduction: The cost-effectiveness of adding bevacizumab biosimilar with or without chemotherapy (CT) and drug wastage in treating platinum-resistant recurrent ovarian cancer (PRrOC) was assessed. Methods: A three-state partitioned-survival model to...
6.
Leung J, Wang S, Leung H, Yu T, Chan A
Sci Rep
. 2024 Jan;
14(1):1892.
PMID: 38253698
The purpose of this study was to assess the risks of hyperthyroidism and hypothyroidism related to gynecological cancers. Population-based retrospective cohort study. We conducted a cohort study using the Taiwan...
7.
Leung J, Tai Y, Wang S, Tsung-Chin H, Yip Fion H, Chan A, et al.
Expert Opin Drug Saf
. 2022 Aug;
22(3):243-252.
PMID: 35998294
Background: Several therapies directed at novel targets and also immunotherapies have recently shown promising results in advanced or metastatic TNBC. We aimed to compare the efficacy and safety of these...
8.
Leung J, Tai Y, Wang S, Yip Fion H, Tsung-Chin H, Chan A
Breast
. 2022 Jul;
65:91-97.
PMID: 35870421
Background: The rising cost of cancer drug therapy threatens the long-term sustainability of Taiwan National Health Insurance. Cost savings can be achieved through various strategies, e.g., using smaller vial sizes,...
9.
Yuan M, Chang S, Yuan M, Foo N, Chan S, Wang S, et al.
Front Med (Lausanne)
. 2022 Jan;
8:764849.
PMID: 34988089
To evaluate the association between radiation exposure from repeated nuclear medicine (NM) examinations and the subsequent risk of neoplasm in pediatric patients. From 2000 to 2017, participants under 18 years...
10.
Chen K, Tsai K, Leung H, Chan A, Wang S, Liang H, et al.
Medicina (Kaunas)
. 2021 Aug;
57(8).
PMID: 34440985
: To evaluate the effectiveness of hepatic arterial infusion chemotherapy (HAIC) followed by lipiodol infusion in advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). : Thirty-two patients with...